Cargando…
Dual gut hormone receptor agonists for diabetes and obesity
Autores principales: | Bass, Joseph, Tschöp, Matthias H., Beutler, Lisa R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888372/ https://www.ncbi.nlm.nih.gov/pubmed/36719381 http://dx.doi.org/10.1172/JCI167952 |
Ejemplares similares
-
Gut hormone polyagonists for the treatment of type 2 diabetes
por: Brandt, Sara J., et al.
Publicado: (2018) -
Obesity hormone leptin: a new target in breast cancer?
por: Surmacz, Eva
Publicado: (2007) -
Gut Microbiota and Stroke
por: Tan, Benjamin Y. Q., et al.
Publicado: (2020) -
Agonist Treatment for Opioid Dependence Syndrome: The Impact of Current Understanding upon Recommendations for Policy Initiatives
por: Dickson, Cheryl, et al.
Publicado: (2021) -
Impact of microbiota on breast cancer hormone therapy
por: Terrisse, Safae, et al.
Publicado: (2023)